Clinical Presentation and Outcomes of Alpha-Gal Syndrome
Clinical Gastroenterology and Hepatology · 2025-01 · 23 (1) · 69-78
DOI: 10.1016/j.cgh.2024.06.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025-01. Verfasst von Elvira Lesmana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Food Hypersensitivity, Tick Bites. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Mayo Clinic.
Abstract (Originalsprache)
BACKGROUND AND AIMS: Alpha-gal syndrome (AGS) is an IgE-mediated allergic reaction to galactose-α-1,3-galactose, primarily linked with Lone Star tick bites in the United States. It presents with symptoms ranging from urticaria and gastrointestinal (GI) manifestations to delayed anaphylaxis following red meat consumption. We aimed to study AGS patients' clinical manifestations, diagnosis, and outcomes. METHODS: A retrospective chart review of patients who underwent serological testing for suspected AGS between 2014 and 2023 at Mayo Clinic was performed. Patients with positive serology were age and sex matched with those who tested negative. Clinical characteristics of seropositive cohort with and without GI symptoms were compared, and outcomes assessed. RESULTS: Of 1260 patients who underwent testing, 124 tested positive for AGS. They were matched with 380 seronegative control subjects. AGS patients reported a higher frequency of tick bites (odds ratio [OR], 26.0; 95% confidence interval [CI], 9.8-68.3), reported a higher prevalence of urticaria (56% vs 37%; P = .0008), and were less likely to have asthma (OR, 0.4; 95% CI, 0.3-0.7). They had a lower prevalence of heartburn (6% vs 12%; P = .03) and bloating (6% vs 13%; P = .03). A total of 47% had GI symptoms, and a higher proportion were female than those without GI symptoms (69% vs 35%; P = .002). During a mean follow-up of 27 months, 22 of 40 patients reported symptom resolution after avoiding red meat, and 7 were able to transition to regular diet. CONCLUSIONS: A diagnosis of AGS should be strongly considered in patients with a history of tick bites and clinical presentation of allergic or GI manifestations. Dietary intervention is effective in most but not all patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
- Division of Rheumatology, Mayo Clinic, Rochester, Minnesota.
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: grover.madhusudan@mayo.edu.
Förderung
- Mayo Clinic
Zitieren
APA
Lesmana, E., Rao, S., Keehn, A., Edwinson, A. L., Makol, A., & Grover, M. (2025). Clinical Presentation and Outcomes of Alpha-Gal Syndrome. Clinical Gastroenterology and Hepatology, 23(1), 69-78. https://doi.org/10.1016/j.cgh.2024.06.044
Vancouver
Lesmana E, Rao S, Keehn A, Edwinson AL, Makol A, Grover M. Clinical Presentation and Outcomes of Alpha-Gal Syndrome. Clinical Gastroenterology and Hepatology. 2025;23(1):69-78. doi:10.1016/j.cgh.2024.06.044
BibTeX
@article{Lesmana2025,
author = {Lesmana, Elvira and Rao, Sameer and Keehn, Ashley and Edwinson, Adam L and Makol, Ashima and Grover, Madhusudan},
title = {Clinical Presentation and Outcomes of Alpha-Gal Syndrome},
journal = {Clinical Gastroenterology and Hepatology},
year = {2025},
volume = {23},
number = {1},
pages = {69--78},
doi = {10.1016/j.cgh.2024.06.044}
}
EUVIMED